UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of the pre amorphization by Ge implantation on Ni0.9Pt0.1 silicide

Microelectronic engineering, 2022-02, Vol.254, p.111705, Article 111705

2022

Volltextzugriff (PDF)

Nanoscale effect on the formation of the amorphous Ni silicide by rapid thermal annealing from crystalline and pre-amorphized silicon

Acta materialia, 2024-01, Vol.262, p.119430, Article 119430

2024

Volltextzugriff (PDF)

Evolution of the Ni0.9Pt0.1/Si system under annealing via nano-crystalline textured phases

Journal of applied physics, 2023-07, Vol.134 (3)

2023

Volltextzugriff (PDF)

Impact of the pre amorphization by Ge implantation on Ni$_{0.9}$Pt$_{0.1}$ silicide

Microelectronic engineering, 2022-02, Vol.254

2022

Volltextzugriff (PDF)

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma

Haematologica (Roma), 2013-07, Vol.98 (7), p.1107-1114

2013

Volltextzugriff (PDF)

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Leukemia, 2014-12, Vol.28 (12), p.2367-2375

2014

Volltextzugriff (PDF)

Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study

Haematologica (Roma), 2011-08, Vol.96 (8), p.1128-1135

2011

Volltextzugriff (PDF)

High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1113-1119

2017

Volltextzugriff (PDF)

Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

The New England journal of medicine, 2004-03, Vol.350 (13), p.1287-1295

2004

Volltextzugriff (PDF)

A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

Blood, 2006-01, Vol.107 (1), p.190-196

2006

Volltextzugriff (PDF)

R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study

Annals of hematology, 2020-07, Vol.99 (7), p.1605-1613

2020

Volltextzugriff (PDF)

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up

Annals of oncology, 2012-09, Vol.23 (9), p.2380-2385

2012

Volltextzugriff (PDF)

Added Value of Spectroscopy to Perfusion MRI in the Differential Diagnostic Performance of Common Malignant Brain Tumors

American journal of neuroradiology : AJNR, 2018-08, Vol.39 (8), p.1423-1431

2018

Volltextzugriff (PDF)

Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders

Kidney international, 2019-07, Vol.96 (1), p.94-103

2019

Volltextzugriff (PDF)

role for T cell-derived interleukin 22 in psoriatic skin inflammation

Clinical and experimental immunology, 2007-12, Vol.150 (3), p.407-415

2007

Volltextzugriff (PDF)

Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation

Clinical and experimental immunology, 2009-10, Vol.158 (1), p.115-124

2009

Volltextzugriff (PDF)

Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR)

Hematological oncology, 2023-06, Vol.41 (S2), p.437-437

2023

Volltextzugriff (PDF)

Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation

Journal of cellular physiology, 2005-08, Vol.204 (2), p.428-436

2005

Volltextzugriff (PDF)

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

Bone marrow transplantation (Basingstoke), 2006-09, Vol.38 (6), p.417-420

2006

Volltextzugriff (PDF)

Treatment of pediatric Erdheim‐Chester disease with interleukin‐1–targeting drugs

Arthritis & rheumatology (Hoboken, N.J.), 2011-12, Vol.63 (12), p.4031-4032

2011

Volltextzugriff (PDF)

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study

Blood, 2012-04, Vol.119 (16), p.3698-3704

2012

Volltextzugriff (PDF)

Treatment of Erdheim-Chester disease with canakinumab

Rheumatology, 2014-12, Vol.53 (12), p.2312-2314

2014

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(78)
Französisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Humans
(46)
Life Sciences & Biomedicine
(44)
Female
(33)
Middle Aged
(32)
Male
(31)
Biological And Medical Sciences
(28)
Adult
(27)
Hematology
(26)
Medical Sciences
(26)
Aged
(18)
Hematologic And Hematopoietic Diseases
(18)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(18)
Adolescent
(15)
Life Sciences
(15)
Lymphoma
(15)
Oncology
(14)
Follow-Up Studies
(13)
Treatment Outcome
(13)
Disease-Free Survival
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Impact of the pre amorphization by Ge implantation on Ni0.9Pt0.1 silicide

Nanoscale effect on the formation of the amorphous Ni silicide by rapid thermal annealing from crystalline and pre-amorphized silicon

Evolution of the Ni0.9Pt0.1/Si system under annealing via nano-crystalline textured phases

Impact of the pre amorphization by Ge implantation on Ni$_{0.9}$Pt$_{0.1}$ silicide

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study

High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study

Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up

Added Value of Spectroscopy to Perfusion MRI in the Differential Diagnostic Performance of Common Malignant Brain Tumors

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation

Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma

role for T cell-derived interleukin 22 in psoriatic skin inflammation

Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation

Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR)

Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

Treatment of pediatric Erdheim‐Chester disease with interleukin‐1–targeting drugs

Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study

Treatment of Erdheim-Chester disease with canakinumab

Suchergebnisse filtern